AU7738281A - Quick disintigrating tablets with delayed release release pharmacological action - Google Patents

Quick disintigrating tablets with delayed release release pharmacological action

Info

Publication number
AU7738281A
AU7738281A AU77382/81A AU7738281A AU7738281A AU 7738281 A AU7738281 A AU 7738281A AU 77382/81 A AU77382/81 A AU 77382/81A AU 7738281 A AU7738281 A AU 7738281A AU 7738281 A AU7738281 A AU 7738281A
Authority
AU
Australia
Prior art keywords
release
quick
tablets
disintigrating
delayed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU77382/81A
Other versions
AU552861B2 (en
Inventor
Helmut Kopf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of AU7738281A publication Critical patent/AU7738281A/en
Application granted granted Critical
Publication of AU552861B2 publication Critical patent/AU552861B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Control Of Presses (AREA)
  • Blow-Moulding Or Thermoforming Of Plastics Or The Like (AREA)
  • Fertilizing (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Golf Clubs (AREA)
  • Measurement Of Force In General (AREA)
  • Dental Preparations (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Quick-disintegrating pressed shapes e.g. tablets containing pharmaceutical active substances, which shapes consist essentially of a compressed mixture of a) a pharmaceutical active substance in a granular delayed-release form, and b) a disintegrating agent having a high disintegrating capacity as well as good binding properties. The pharmaceutical active substance is coated with a mixture of ethyl cellulose and a polyacrylate to provide the delayed-release form.
AU77382/81A 1980-11-12 1981-11-11 Quick disintigrating tablets with delayed release release pharmacological action Ceased AU552861B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH8393/80 1980-11-12
CH839380 1980-11-12

Publications (2)

Publication Number Publication Date
AU7738281A true AU7738281A (en) 1982-05-20
AU552861B2 AU552861B2 (en) 1986-06-26

Family

ID=4339640

Family Applications (1)

Application Number Title Priority Date Filing Date
AU77382/81A Ceased AU552861B2 (en) 1980-11-12 1981-11-11 Quick disintigrating tablets with delayed release release pharmacological action

Country Status (20)

Country Link
EP (1) EP0052076B1 (en)
JP (1) JPS57109715A (en)
AT (1) ATE13486T1 (en)
AU (1) AU552861B2 (en)
CA (1) CA1178202A (en)
CY (1) CY1429A (en)
DE (1) DE3170764D1 (en)
DK (1) DK154537C (en)
ES (1) ES506981A0 (en)
FI (1) FI76254C (en)
GB (1) GB2086725B (en)
GR (1) GR76337B (en)
HK (1) HK53388A (en)
IE (1) IE51827B1 (en)
IL (1) IL64255A0 (en)
MY (1) MY8700132A (en)
NO (1) NO157964C (en)
NZ (1) NZ198937A (en)
PT (1) PT73963B (en)
ZA (1) ZA817795B (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3314003A1 (en) * 1983-04-18 1984-10-18 Boehringer Ingelheim KG, 6507 Ingelheim DIVISIBLE TABLET WITH DELAYED ACTIVE SUBSTANCE RELEASE AND METHOD FOR THE PRODUCTION THEREOF
CH658188A5 (en) * 1984-03-23 1986-10-31 Ciba Geigy Ag STORAGE STABLE QUICK DISASSEMBLING PHARMACEUTICAL PRESSELS.
JPS6144811A (en) * 1984-08-10 1986-03-04 Ss Pharmaceut Co Ltd Sustained release diclofenac sodium pharmaceutical
IE59066B1 (en) * 1985-02-19 1993-12-15 Key Pharma Controlled release potassium chloride
JPS61210025A (en) * 1985-03-14 1986-09-18 Teisan Seiyaku Kk Stabilized antibioitc complex granule preparation
WO1987001936A1 (en) * 1985-09-25 1987-04-09 Gerhard Gergely Desintegration tablet and process for its manufacture
KR880701098A (en) * 1986-04-01 1988-07-25 로버어트 에이 아미테이지 Methylprednisolone / sodium carboxymethyl starch tablet composition
GB8628359D0 (en) * 1986-11-27 1986-12-31 Zyma Sa Galenical formulation
GB8702411D0 (en) * 1987-02-03 1987-03-11 Zyma Sa Swellable pellets
GB8707421D0 (en) * 1987-03-27 1987-04-29 Wellcome Found Pharmaceutical formulations
GB8707416D0 (en) * 1987-03-27 1987-04-29 Wellcome Found Pharmaceutical formulations
GB8724763D0 (en) * 1987-10-22 1987-11-25 Aps Research Ltd Sustained-release formulations
CH675537A5 (en) * 1988-03-25 1990-10-15 Ciba Geigy Ag
JPH0273011A (en) * 1988-07-28 1990-03-13 Warner Lambert Co Aqueous polymer dispersion of cellulose and acrylic polymer for preparing drug administration form
JP2514078B2 (en) * 1988-08-22 1996-07-10 エスエス製薬株式会社 Compressed formulation
MY110880A (en) * 1991-01-30 1999-06-30 The Wellcome Foundation Ltd Water-dispersible tablets
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
US6245351B1 (en) * 1996-03-07 2001-06-12 Takeda Chemical Industries, Ltd. Controlled-release composition
FR2766089B1 (en) * 1997-07-21 2000-06-02 Prographarm Lab IMPROVED MULTIPARTICULAR TABLET WITH RAPID DELIVERY
WO2005013964A1 (en) * 2003-08-08 2005-02-17 Ajinomoto Co., Inc. Pharmaceutical preparation containing nateglinide
JP5122380B2 (en) * 2008-06-16 2013-01-16 エーザイ・アール・アンド・ディー・マネジメント株式会社 Quick-disintegrating tablet with controlled drug release and process for producing the same
EP2253306A1 (en) * 2009-05-18 2010-11-24 Royal College of Surgeons in Ireland Orodispersible dosage forms containing solid drug dispersions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2336218C3 (en) * 1973-07-17 1985-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Oral dosage form
US4143129A (en) * 1975-10-11 1979-03-06 Lilly Industries Limited Cephalexin tablets
GB1560475A (en) * 1975-10-11 1980-02-06 Lilly Industries Ltd Pharmaceutical formulation
US4140756A (en) * 1976-06-10 1979-02-20 Mead Johnson & Company Film-coated matrix core tablet

Also Published As

Publication number Publication date
FI76254B (en) 1988-06-30
CY1429A (en) 1988-09-02
ATE13486T1 (en) 1985-06-15
EP0052076B1 (en) 1985-05-29
GB2086725A (en) 1982-05-19
NO157964B (en) 1988-03-14
NO157964C (en) 1988-06-29
PT73963A (en) 1981-12-01
JPH0228564B2 (en) 1990-06-25
ES8303090A1 (en) 1983-02-01
IL64255A0 (en) 1982-02-28
DK154537B (en) 1988-11-28
JPS57109715A (en) 1982-07-08
ZA817795B (en) 1982-10-27
DK499181A (en) 1982-05-13
IE812643L (en) 1982-05-12
CA1178202A (en) 1984-11-20
NO813826L (en) 1982-05-13
GR76337B (en) 1984-08-04
HK53388A (en) 1988-07-22
DK154537C (en) 1989-04-17
AU552861B2 (en) 1986-06-26
EP0052076A1 (en) 1982-05-19
IE51827B1 (en) 1987-04-01
MY8700132A (en) 1987-12-31
DE3170764D1 (en) 1985-07-04
ES506981A0 (en) 1983-02-01
PT73963B (en) 1983-11-23
FI76254C (en) 1988-10-10
FI813532L (en) 1982-05-13
NZ198937A (en) 1985-04-30
GB2086725B (en) 1985-08-21

Similar Documents

Publication Publication Date Title
AU552861B2 (en) Quick disintigrating tablets with delayed release release pharmacological action
AU579355B2 (en) Storage-stable, quick disintegrating pressed shapes containing pharmaceutical active substances
IL53594A (en) Biological cells comprising pharmaceutically active substances and additives controlling their release from the cells,their preparation and pharmaceutical compositions containing them
HUT47570A (en) Insecticides containing as active substance 3-substituated-1-/chlor-tiasole-5-il-methil/-2-nitroamin-1,3-diaza-cycloalkans and process for production of the active substances
NZ218734A (en) Tablets containing coated microspheres which contain ibuprofen (2-(4-isobutyl phenyl)propanoic acid)
ZA884622B (en) Pharmaceutical compositions in the form of pellets with enzymatically controlled release of the pharmaceutical,substance
DE3569471D1 (en) A therapeutic preparation having ammonium nitrate as its active substance
JPS5420126A (en) Pharmaceutical composition
JPS52109498A (en) Production of granulated zeolite
DE3469438D1 (en) Novel, physiologically active substance, process for production thereof and pharmaceutical composition containing the same
IL68779A0 (en) Pharmaceutical mixture with controlled release of active substance
JPS53133240A (en) Fluorescent coating composition